|Articles|September 15, 2006

Supplements and Featured Publications

  • Express Report - New Directions and Options for the Management of Hypertension
  • Volume 12
  • Issue 1 Express

Ability to Control Blood Pressure and Choice of Antihypertensive Impact Development and Course of Comorbid Disease

Download PDF: Ability to Control Blood Pressure and Choice of Antihypertensive Impact Development and Course of Comorbid Disease

Articles in this issue

over 19 years ago

Introduction

over 19 years ago

New Direct Renin Inhibitor as Monotherapy or in Combination with Hydrochlorothiazide Controls Blood Pressure

over 19 years ago

Valsartan Reduces Inflammatory Marker Associated with Hypertensive and Comorbid Risk; Effect Neutralized by Thiazide Diuretic

over 19 years ago

The Impact of Fixed-dose Combinations on Blood Pressure Control, Persistence, and Comorbid Disease

over 19 years ago

Initial Drug Choice and Economics Affect Healthcare Utilization and Persistence

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text